compounding law, 503A pharmacies may compound from an FDA-approved drug product, from a substance with a USP or NF monograph, or from a substance on the 503A bulks list
Pancreatitis, thyroid concerns, and gallbladder complications are rare but serious potential risks with GLP-1 therapy in any patient
The safety considerations and side effects of Glutathione IV for skin brightening include liver dysfunction, anaphylaxis, and kidney injury
Overall, sitagliptin were better tolerated, with lower absolute rates of adverse effects
Clinical evidence, encompassing trials, epidemiological investigations, and findings from animal toxicology and histological studies, has revealed potential associations between GLP-1RAs and the risk of neuroendocrine tumors and exocrine pancreatic dysplasia, with some evidence suggesting an increased risk of pancreatic cancer [6]
The SLIM LIVER study showed trends toward improved gait speed even with decreased psoas muscle volume
